Propofol directly increases tau phosphorylation

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Whittington, Robert A ^a   Virág, László ^a   Marcouiller, François ^b   Papon, Marie Amélie ^b   El Khoury, Noura B ^b   Julien, Carl ^b   Morin, Françoise ^b   Emala, Charles W ^a   Planel, Emmanuel ^b  

^a Columbia University ^*  (United States)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; PHOSPHOPROTEIN PHOSPHATASE 2A; PROPOFOL; TAU PROTEIN; HYPNOTIC SEDATIVE AGENT; INTRAVENOUS ANESTHETIC AGENT;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; GENE OVEREXPRESSION; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SOMATOTYPE; ANIMAL; DRUG EFFECT; METABOLISM; PHOSPHORYLATION;

ANESTHETICS, INTRAVENOUS; ANIMALS; CEREBRAL CORTEX; HIPPOCAMPUS; HYPNOTICS AND SEDATIVES; MICE; PHOSPHORYLATION; PROPOFOL; TAU PROTEINS;

EID: 79551614976     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016648     Document Type: Article

References (48)

1. Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer's disease. Alzheimers Dement 3: 186-191.
2. Glenner GG, Wong CW (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120: 885-890.
3. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung YC, Zaidi MS, et al. (1986) Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 261: 6084-6089.
4. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, et al. (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83: 4913-4917.
5. Montejo de Garcini E, Serrano L, Avila J (1986) Self assembly of microtubule associated protein tau into filaments resembling those found in Alzheimer disease. Biochem Biophys Res Commun 141: 790-796.
6. Alonso A, Zaidi T, Novak M, Grundke-Iqbal I, Iqbal K (2001) Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/ straight filaments. Proc Natl Acad Sci U S A 98: 6923-6928.
7. Baranov D, Bickler PE, Crosby GJ, Culley DJ, Eckenhoff MF, et al. (2009) Consensus statement: First International Workshop on Anesthetics and Alzheimer's disease. Anesth Analg 108: 1627-1630.
8. Eckenhoff RG, Eckenhoff MF (2007) Anesthesia, Amyloid and Alzheimer's. Cellscience Reviews. pp 78-96.
9. Run X, Liang Z, Gong CX (2010) Anesthetics and Tau Protein: Animal Model Studies. J Alzheimers Dis.
10. Papon MA, Whittington RA, El Khoury N, Planel E (2011) Alzheimer's disease and anesthesia. Frontiers in Neurodegenerative Diseases in Press.
11. Bianchi SL, Tran T, Liu C, Lin S, Li Y, et al. (2008) Brain and behavior changes in 12-month-old Tg2576 and nontransgenic mice exposed to anesthetics. Neurobiol Aging 29: 1002-1010.
12. Eckenhoff RG, Johansson JS, Wei H, Carnini A, Kang B, et al. (2004) Inhaled anesthetic enhancement of amyloid-beta oligomerization and cytotoxicity. Anesthesiology 101: 703-709.
13. Xie Z, Dong Y, Maeda U, Alfille P, Culley DJ, et al. (2006) The common inhalation anesthetic isoflurane induces apoptosis and increases amyloid beta protein levels. Anesthesiology 104: 988-994.
14. Xie Z, Dong Y, Maeda U, Moir RD, Xia W, et al. (2007) The inhalation anesthetic isoflurane induces a vicious cycle of apoptosis and amyloid betaprotein accumulation. J Neurosci 27: 1247-1254.
15. Planel E, Richter KE, Nolan CE, Finley JE, Liu L, et al. (2007) Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia. J Neurosci 27: 3090-3097.
16. Planel E, Krishnamurthy P, Miyasaka T, Liu L, Herman M, et al. (2008) Anesthesia-induced hyperphosphorylation detaches 3-repeat tau from microtubules without affecting their stability in vivo. J Neurosci 28: 12798-12807.
17. Planel E, Bretteville A, Liu L, Virag L, Du AL, et al. (2009) Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia. Faseb J doi:10.1096/fj.08-122424.
18. Run X, Liang Z, Zhang L, Iqbal K, Grundke-Iqbal I, et al. (2009) Anesthesia induces phosphorylation of tau. J Alzheimers Dis 16: 619-626.
19. Wunsch H, Kahn JM, Kramer AA, Rubenfeld GD (2009) Use of intravenous infusion sedation among mechanically ventilated patients in the United States. Crit Care Med 37: 3031-3039.
20. Su JH, Cummings BJ, Cotman CW (1994) Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites. Neuroreport 5: 2358-2362.
21. Zhu X, Lee HG, Raina AK, Perry G, Smith MA (2002) The role of mitogenactivated protein kinase pathways in Alzheimer's disease. Neurosignals 11: 270-281.
22. Planel E, Sun X, Takashima A (2002) Role of GSK-3 beta in Alzheimer's disease pathology. Drug Development Research 56: 491-510.
23. Maccioni RB, Otth C, Concha II, Munoz JP (2001) The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology. Eur J Biochem 268: 1518-1527.
24. Sadik G, Tanaka T, Kato K, Yamamori H, Nessa BN, et al. (2009) Phosphorylation of tau at Ser214 mediates its interaction with 14-3-3 protein: implications for the mechanism of tau aggregation. J Neurochem 108: 33-43.
25. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789.
26. Litersky JM, Johnson GV, Jakes R, Goedert M, Lee M, et al. (1996) Tau protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium/ calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356. Biochem J 316: 655-660.
27. Wang JZ, Grundke-Iqbal I, Iqbal K (1996) Restoration of biological activity of Alzheimer abnormally phosphorylated tau by dephosphorylation with protein phosphatase-2A, - 2B and -1. Brain Res 38: 200-208.
28. Goedert M, Cohen ES, Jakes R, Cohen P (1992) p42 MAP kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1. Implications for Alzheimer's disease [corrected] [published erratum appears in FEBS Lett 1992 Nov 23;313(2): 203]. FEBS Lett 312: 95-99.
29. Engdahl O, Abrahams M, Bjornsson A, Vegfors M, Norlander B, et al. (1998) Cerebrospinal fluid concentrations of propofol during anaesthesia in humans. Br J Anaesth 81: 957-959.
30. Planel E, Miyasaka T, Launey T, Chui DH, Tanemura K, et al. (2004) Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease. J Neurosci 24: 2401-2411.
31. Pei JJ, Gong CX, An WL, Winblad B, Cowburn RF, et al. (2003) Okadaic-acidinduced inhibition of protein phosphatase 2A produces activation of mitogenactivated protein kinases ERK1/2, MEK1/2, and p70 S6, similar to that in Alzheimer's disease. Am J Pathol 163: 845-858.
32. Singh TJ, Grundke-Iqbal I, McDonald B, Iqbal K (1994) Comparison of the phosphorylation of microtubule-associated protein tau by non-proline dependent protein kinases. Mol Cell Biochem 131: 181-189.
33. Tian Q, Wang J (2002) Role of serine/threonine protein phosphatase in Alzheimer's disease. Neurosignals 11: 262-269.
34. Bennecib M, Gong CX, Grundke-Iqbal I, Iqbal K (2000) Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain. FEBS Lett 485: 87-93.
35. Gong CX, Lidsky T, Wegiel J, Zuck L, Grundke-Iqbal I, et al. (2000) Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J Biol Chem 275: 5535-5544.
36. Planel E, Yasutake K, Fujita SC, Ishiguro K (2001) Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse. J Biol Chem 276: 34298-34306.
37. Ehlenbach WJ, Hough CL, Crane PK, Haneuse SJ, Carson SS, et al. (2010) Association between acute care and critical illness hospitalization and cognitive function in older adults. JAMA 303: 763-770.
38. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, et al. (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85.
39. Delobel P, Flament S, Hamdane M, Mailliot C, Sambo AV, et al. (2002) Abnormal Tau phosphorylation of the Alzheimer-type also occurs during mitosis. J Neurochem 83: 412-420.
40. Hamdane M, Sambo AV, Delobel P, Begard S, Violleau A, et al. (2003) Mitoticlike tau phosphorylation by p25-Cdk5 kinase complex. J Biol Chem 278: 34026-34034.
41. Mailliot C, Bussiere T, Hamdane M, Sergeant N, Caillet ML, et al. (2000) Pathological tau phenotypes. The weight of mutations, polymorphisms, and differential neuronal vulnerabilities. Ann N Y Acad Sci 920: 107-114.
42. Oscarsson A, Juhas M, Sjolander A, Eintrei C (2007) The effect of propofol on actin, ERK-1/2 and GABAA receptor content in neurones. Acta Anaesthesiol Scand 51: 1184-1189.
43. Goedert M, Jakes R, Vanmechelen E (1995) Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 189: 167-169.
44. Otvos L, Jr., Feiner L, Lang E, Szendrei GI, Goedert M, et al. (1994) Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res 39: 669-673.
45. Jicha GA, Lane E, Vincent I, Otvos L, Jr., Hoffmann R, et al. (1997) A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease. J Neurochem 69: 2087-2095.
46. Weaver CL, Espinoza M, Kress Y, Davies P (2000) Conformational change as one of the earliest alterations of tau in Alzheimer's disease. Neurobiol Aging 21: 719-727.
47. Jicha GA, Bowser R, Kazam IG, Davies P (1997) Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res 48: 128-132.
48. Planel E, Tatebayashi Y, Miyasaka T, Liu L, Wang L, et al. (2007) Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms. J Neurosci 27: 13635-13648.